NoMy's Mycoprotein Revolution: A Sustainable Protein Future
May 28, 2025, 3:33 pm
In a world grappling with a protein crisis, a Norwegian startup is making waves. NoMy, based in Oslo, has secured €1.25 million in funding to scale its innovative mycoprotein technologies. This investment, led by Nippon Beet Sugar Manufacturing Co., Ltd. (Nitten), marks a significant step toward transforming the food industry.
NoMy is not just another player in the protein game. It’s a pioneer, harnessing the power of fungi to create sustainable protein alternatives. This funding round also saw contributions from notable investors like TD Veen and EIT Food, underscoring the growing interest in sustainable food solutions.
Founded in 2020 by Ingrid Dynna and David Andrew Quist, NoMy combines business savvy with scientific expertise. Dynna, with a rich background at Google, brings a strategic edge. Quist, a microbiologist, adds depth with his experience advising environmental agencies and his culinary ventures. Together, they are on a mission to reshape how we think about protein.
At the heart of NoMy’s innovation is fungal fermentation technology. This process transforms food industry side streams into high-value ingredients. Think of it as turning waste into gold. The mycoprotein produced is not only rich in protein but also packed with fiber and minerals. It’s a versatile ingredient, adaptable to various food applications.
The partnership with Nitten began in 2024, focusing on utilizing resources from beet sugar manufacturing. This collaboration is a game-changer. It allows NoMy to produce mycoprotein without disrupting the sugar supply chain. It’s a win-win, addressing the protein shortage while promoting sustainable agriculture in Japan.
Sustainability is woven into NoMy’s DNA. The company emphasizes the environmental benefits of mycoprotein production. By utilizing fermentation, they tap into natural cycles, offering an eco-friendly alternative to traditional animal and plant proteins. This approach not only diversifies protein sources but also reduces the ecological footprint of food production.
The global protein crisis is a pressing issue. As populations grow, the demand for protein skyrockets. Traditional sources, like meat and dairy, are resource-intensive. They strain the environment and contribute to climate change. NoMy’s mycoprotein offers a solution. It’s a sustainable option that can help meet the rising demand without depleting our planet’s resources.
The potential of mycoprotein extends beyond just human consumption. It can also play a crucial role in aquafeed, supporting the growing aquaculture industry. This dual application enhances its value proposition, making it a versatile ingredient for various markets.
NoMy’s vision aligns with the broader movement toward circular food systems. This concept focuses on minimizing waste and maximizing resource efficiency. By turning side streams into valuable products, NoMy embodies this philosophy. It’s about creating a food system that is regenerative, not extractive.
The funding will enable NoMy to scale its operations and expand its reach. With partnerships in Japan, Norway, and Europe, the company is poised for growth. The collaboration with Nitten is particularly promising, as it opens doors to the Japanese market, known for its high standards in food quality and sustainability.
Ingrid Dynna, the CEO, expresses excitement about the partnership. Nitten’s commitment to sustainability complements NoMy’s mission. Together, they aim to revolutionize the protein landscape, making it more sustainable and resilient.
The journey ahead is filled with challenges. Scaling production while maintaining quality is no small feat. However, NoMy’s proven technology and strategic partnerships position it well for success. The road may be long, but the destination is clear: a sustainable protein future.
As consumers become more conscious of their food choices, the demand for sustainable options will only grow. NoMy is ahead of the curve, ready to meet this demand with innovative solutions. The mycoprotein market is ripe for disruption, and NoMy is leading the charge.
In conclusion, NoMy is not just a startup; it’s a beacon of hope in the fight against the protein crisis. With its innovative mycoprotein technologies and commitment to sustainability, it’s paving the way for a more resilient food system. The future of protein is here, and it’s fungal. As we look ahead, one thing is clear: NoMy is poised to change the way we think about food, one mycoprotein at a time.
NoMy is not just another player in the protein game. It’s a pioneer, harnessing the power of fungi to create sustainable protein alternatives. This funding round also saw contributions from notable investors like TD Veen and EIT Food, underscoring the growing interest in sustainable food solutions.
Founded in 2020 by Ingrid Dynna and David Andrew Quist, NoMy combines business savvy with scientific expertise. Dynna, with a rich background at Google, brings a strategic edge. Quist, a microbiologist, adds depth with his experience advising environmental agencies and his culinary ventures. Together, they are on a mission to reshape how we think about protein.
At the heart of NoMy’s innovation is fungal fermentation technology. This process transforms food industry side streams into high-value ingredients. Think of it as turning waste into gold. The mycoprotein produced is not only rich in protein but also packed with fiber and minerals. It’s a versatile ingredient, adaptable to various food applications.
The partnership with Nitten began in 2024, focusing on utilizing resources from beet sugar manufacturing. This collaboration is a game-changer. It allows NoMy to produce mycoprotein without disrupting the sugar supply chain. It’s a win-win, addressing the protein shortage while promoting sustainable agriculture in Japan.
Sustainability is woven into NoMy’s DNA. The company emphasizes the environmental benefits of mycoprotein production. By utilizing fermentation, they tap into natural cycles, offering an eco-friendly alternative to traditional animal and plant proteins. This approach not only diversifies protein sources but also reduces the ecological footprint of food production.
The global protein crisis is a pressing issue. As populations grow, the demand for protein skyrockets. Traditional sources, like meat and dairy, are resource-intensive. They strain the environment and contribute to climate change. NoMy’s mycoprotein offers a solution. It’s a sustainable option that can help meet the rising demand without depleting our planet’s resources.
The potential of mycoprotein extends beyond just human consumption. It can also play a crucial role in aquafeed, supporting the growing aquaculture industry. This dual application enhances its value proposition, making it a versatile ingredient for various markets.
NoMy’s vision aligns with the broader movement toward circular food systems. This concept focuses on minimizing waste and maximizing resource efficiency. By turning side streams into valuable products, NoMy embodies this philosophy. It’s about creating a food system that is regenerative, not extractive.
The funding will enable NoMy to scale its operations and expand its reach. With partnerships in Japan, Norway, and Europe, the company is poised for growth. The collaboration with Nitten is particularly promising, as it opens doors to the Japanese market, known for its high standards in food quality and sustainability.
Ingrid Dynna, the CEO, expresses excitement about the partnership. Nitten’s commitment to sustainability complements NoMy’s mission. Together, they aim to revolutionize the protein landscape, making it more sustainable and resilient.
The journey ahead is filled with challenges. Scaling production while maintaining quality is no small feat. However, NoMy’s proven technology and strategic partnerships position it well for success. The road may be long, but the destination is clear: a sustainable protein future.
As consumers become more conscious of their food choices, the demand for sustainable options will only grow. NoMy is ahead of the curve, ready to meet this demand with innovative solutions. The mycoprotein market is ripe for disruption, and NoMy is leading the charge.
In conclusion, NoMy is not just a startup; it’s a beacon of hope in the fight against the protein crisis. With its innovative mycoprotein technologies and commitment to sustainability, it’s paving the way for a more resilient food system. The future of protein is here, and it’s fungal. As we look ahead, one thing is clear: NoMy is poised to change the way we think about food, one mycoprotein at a time.